Choolip & Sciences

291650 · KOSDAQ · Industrials · SMALL CAP

Revenue up 223.6% in FY2025.

Choolip & Sciences reported separate results for FY2025: revenue of US$2.37M (+223.6% year on year), an operating loss of US$5.27M and a net loss of US$5.83M.

Earnings(Change of 30% or more in revenue or profit/loss structure (15% for large companies))· FILED 2026-03-06· RCEPT 20260306901123

US$2.37MRevenue
+223.6%Revenue vs a year earlier
−US$5.27MOperating profit

Converted at 1 USD ≈ ₩1,479.51 (filing-date rate, 2026-03-06 close)

What happened

Choolip & Sciences reported separate results for FY2025: revenue of US$2.37M (+223.6% year on year), an operating loss of US$5.27M and a net loss of US$5.83M.

Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.

RevenueUS$2.37M
Revenue vs a year earlier+223.6%
Operating profit−US$5.27M
Net income−US$5.83M
PeriodFY2025 (separate)
Filed2026-03-06, Change of 30% or more in revenue or profit/loss structure (15% for large companies)
SourceDART rcept 20260306901123 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-03-06 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.